SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mahasen Abdel-Rahman, Yasmin Saad, Maissa El-Raziky, Naglaa Zayed, Wafaa El-Akel, Mohamed Said, Mohamed El-Beshlawy, Gamal Esmat, Hepatitis C genotype 4 with normal transaminases: Correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients, Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 5, 479

    CrossRef

  2. You have free access to this content2
    G. Nunnari, M. R. Pinzone, B. Cacopardo, Lack of clinical and histological progression of chronic hepatitis C in individuals with true persistently normal ALT: the result of a 17-year follow-up, Journal of Viral Hepatitis, 2013, 20, 4
  3. 3
    L. Pacifico, F. Ferraro, E. Bonci, C. Anania, S. Romaggioli, C. Chiesa, Upper limit of normal for alanine aminotransferase: Quo vadis?, Clinica Chimica Acta, 2013, 422, 29

    CrossRef

  4. 4
    Mohamed A. Abdelmegeed, Atrayee Banerjee, Seong-Ho Yoo, Sehwan Jang, Frank J. Gonzalez, Byoung-Joon Song, Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis, Journal of Hepatology, 2012, 57, 4, 860

    CrossRef

  5. 5
    Mamie H. Dong, Ricki Bettencourt, David A. Brenner, Elizabeth Barrett–Connor, Rohit Loomba, Serum Levels of Alanine Aminotransferase Decrease With Age in Longitudinal Analysis, Clinical Gastroenterology and Hepatology, 2012, 10, 3, 285

    CrossRef

  6. 6
    H. Chung, T. Watanabe, M. Kudo, T. Chiba, Correlation between hyporesponsiveness to Toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection, Journal of Viral Hepatitis, 2011, 18, 10
  7. 7
    P. Burra, E. De Martin, Infections and Organ Transplantation: New Challenges for Prevention and Treatment of Hepatitis C Virus, Transplantation Proceedings, 2011, 43, 6, 2455

    CrossRef

  8. 8
    Juliane I. Beier, J. Phillip Kaiser, Luping Guo, Manuel Martínez-Maldonado, Gavin E. Arteel, Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis, Archives of Biochemistry and Biophysics, 2011, 510, 1, 19

    CrossRef

  9. 9
    G. Sebastiani, L. Castera, P. Halfon, S. Pol, A. Mangia, V. Di Marco, M. Pirisi, M. Voiculescu, M. Bourliere, A. Alberti, The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases, Alimentary Pharmacology & Therapeutics, 2011, 34, 10
  10. 10
    Yusuf Yilmaz, Ramazan Kurt, Cem Kalayci, Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments, Biomarkers in Medicine, 2010, 4, 5, 743

    CrossRef

  11. 11
    Enikő Sárváry, Zs. Gerlei, E. Dinya, E. Tóth, M. Varga, R. Chmel, M. Molnar, A. Remport, B. Nemes, L. Kobori, D. Görög, J. Fazakas, I. Gaal, J. Járay, F. Perner, R. Langer, Hepatitis C infected hemodialysis and renal transplant patients with elevated <i>α</i>-glutathione S-transferase have increased risk for liver damage, Interventional Medicine and Applied Science, 2010, 2, 2, 70

    CrossRef

  12. 12
    Aijaz Ahmed, Paul Martin, Assessing and Managing Hepatobiliary Disease,